(Q34038886)

English

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies (English)

1 reference

Europe PubMed Central

30 July 2017

sickle-cell disease

0 references

0 references

1 reference

based on heuristic

inferred from title

pulmonary hypertension

1 reference

based on heuristic

inferred from title

Mark T. Gladwin

11

object named as

Mark T Gladwin

1 reference

Europe PubMed Central

30 July 2017

1

object named as

Robyn J Barst

1 reference

Europe PubMed Central

30 July 2017

author name string

Kamal K Mubarak

2

1 reference

Europe PubMed Central

30 July 2017

Roberto F Machado

3

1 reference

Europe PubMed Central

30 July 2017

Kenneth I Ataga

4

1 reference

Europe PubMed Central

30 July 2017

Raymond L Benza

5

1 reference

Europe PubMed Central

30 July 2017

Oswaldo Castro

6

1 reference

Europe PubMed Central

30 July 2017

Robert Naeije

7

1 reference

Europe PubMed Central

30 July 2017

Namita Sood

8

1 reference

Europe PubMed Central

30 July 2017

Paul S Swerdlow

9

1 reference

Europe PubMed Central

30 July 2017

Mariana Hildesheim

10

1 reference

Europe PubMed Central

30 July 2017

ASSET study group*

12

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

17 February 2010

1 reference

Europe PubMed Central

30 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

30 July 2017

149

1 reference

Europe PubMed Central

30 July 2017

426-435

1 reference

Europe PubMed Central

30 July 2017

3

1 reference

Europe PubMed Central

30 July 2017

Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Nitric oxide therapy in sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Elevated plasma endothelin-1 levels in sickle cell anemia: relationships to oxygen saturation and left ventricular hypertrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

5 July 2018

N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

29 October 2018

Pulmonary hypertension in patients with sickle cell disease: a longitudinal study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

29 October 2018

Pulmonary hypertension in sickle cell disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

29 October 2018

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

29 October 2018

Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

29 October 2018

Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

29 October 2018

Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

29 October 2018

Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914575

29 October 2018

Modulation of Gardos channel activity by cytokines in sickle erythrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20175775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20175775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary complications of sickle cell disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20175775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelin-1 Production during the Acute Chest Syndrome in Sickle Cell Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20175775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased levels of endothelin-1 in plasma of sickle cell anemia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20175775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2141.2010.08097.X

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34038886&oldid=1953129938"